RCM
CTIC

Rotella Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Rotella Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,367
Closed -$85K – 772
2015
Q2 		$85K Buy
+4,367
New +$84.3K 0.07% 301
2015
Q1 		– Sell
-2,659
Closed -$63K – 684
2014
Q4 		$63K Buy
+2,659
New +$61.5K 0.05% 284
2014
Q3 		– Sell
-1,980
Closed -$56K – 491
2014
Q2 		$56K Buy
+1,980
New +$59.5K 0.05% 299
2013
Q4 		– Sell
-1,090
Closed -$18K – 176
2013
Q3 		$18K Sell
1,090
-1,610
-60% -$18.7K 0.03% 128
2013
Q2 		$28K Buy
+2,700
New +$31.6K 0.09% 122

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return